Literature DB >> 1792870

Concomitant Creutzfeldt-Jakob and Alzheimer diseases.

J M Powers1, Y Liu, L S Hair, R J Kascsack, L D Lewis, L A Levy.   

Abstract

We report a 69-year-old female with cerebral and cerebellar symptomatology of 15-month duration. At autopsy, both panencephalopathic Creutzfeldt-Jakob and plaque-predominant Alzheimer diseases were found. Plaque amyloid was exclusively of the beta/A4 type, but abundant abnormal protease-resistant protein was identified by Western blot analysis of brain extracts.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1792870     DOI： 10.1007/bf00294437

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


  8 in total

1.  Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.

Authors:  T Kitamoto; J Tateishi; T Tashima; I Takeshita; R A Barry; S J DeArmond; S B Prusiner
Journal:  Ann Neurol       Date:  1986-08       Impact factor: 10.422

2.  Coexistence of Creutzfeldt-Jakob disease and Alzheimer's disease in the same patient.

Authors:  P Brown; F Jannotta; C J Gibbs; H Baron; D C Guiroy; D C Gajdusek
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

3.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue.

Authors:  P Brown; M Coker-Vann; K Pomeroy; M Franko; D M Asher; C J Gibbs; D C Gajdusek
Journal:  N Engl J Med       Date:  1986-02-27       Impact factor: 91.245

5.  Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles.

Authors:  R D Terry; L A Hansen; R DeTeresa; P Davies; H Tobias; R Katzman
Journal:  J Neuropathol Exp Neurol       Date:  1987-05       Impact factor: 3.685

6.  Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter.

Authors:  T Mizutani; A Okumura; M Oda; H Shiraki
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

7.  Creutzfeldt-Jakob disease with plaques and paired helical filaments.

Authors:  P P Liberski; W Papierz; J Alwasiak
Journal:  Acta Neurol Scand       Date:  1987-12       Impact factor: 3.209

8.  Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies.

Authors:  C L Masters; D C Gajdusek; C J Gibbs
Journal:  Brain       Date:  1981-09       Impact factor: 13.501
  8 in total
  10 in total

Review 1.  Current status review: cerebral amyloid.

Authors:  L W Duchen
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

2.  Amyloid-β Activates Microglia and Regulates Protein Expression in a Manner Similar to Prions.

Authors:  Jian Tu; Baian Chen; Lifeng Yang; Kezong Qi; Jing Lu; Deming Zhao
Journal:  J Mol Neurosci       Date:  2015-04-14       Impact factor: 3.444

3.  Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting.

Authors:  M Preusser; T Ströbel; E Gelpi; M Eiler; G Broessner; E Schmutzhard; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

4.  The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration.

Authors:  T Muramoto; T Kitamoto; H Koga; J Tateishi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Creutzfeldt-Jakob disease and cerebral amyloid angiopathy.

Authors:  F Gray; F Chrétien; P Cesaro; J Chatelain; P Beaudry; J L Laplanche; J Mikol; J Bell; P Gambetti; J D Degos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype.

Authors:  Nupur Ghoshal; Ignazio Cali; Richard Justin Perrin; S Andrew Josephson; Ning Sun; Pierluigi Gambetti; John Carl Morris
Journal:  Arch Neurol       Date:  2009-10

7.  PrP106-126 and Aβ 1-42 peptides induce BV-2 microglia chemotaxis and proliferation.

Authors:  Jian Tu; LiFeng Yang; XiangMei Zhou; KeZong Qi; JinGuo Wang; Mohammed Kouadir; LiHua Xu; XiaoMin Yin; DeMing Zhao
Journal:  J Mol Neurosci       Date:  2013-11-13       Impact factor: 3.444

8.  Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein.

Authors:  Edward T Parkin; Nicole T Watt; Ishrut Hussain; Elizabeth A Eckman; Christopher B Eckman; Jean C Manson; Herbert N Baybutt; Anthony J Turner; Nigel M Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-15       Impact factor: 11.205

9.  Production of seedable Amyloid-β peptides in model of prion diseases upon PrPSc-induced PDK1 overactivation.

Authors:  Juliette Ezpeleta; Vincent Baudouin; Zaira E Arellano-Anaya; François Boudet-Devaud; Mathéa Pietri; Anne Baudry; Anne-Marie Haeberlé; Yannick Bailly; Odile Kellermann; Jean-Marie Launay; Benoit Schneider
Journal:  Nat Commun       Date:  2019-08-01       Impact factor: 14.919

10.  Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.

Authors:  Makoto Hashimoto; Gilbert Ho; Yoshiki Takamatsu; Ryoko Wada; Shuei Sugama; Masaaki Waragai; Eliezer Masliah; Takato Takenouchi
Journal:  Prion       Date:  2020-12       Impact factor: 3.931
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.